Chief Executive Officer Mike Doustdar warned, “People should expect that it goes down before it comes back up,” citing pressure from significantly lower US pricing on its blockbuster weight-loss drug ...

Shares in the Danish pharmaceuticals group Novo Nordisk plunged Wednesday after the maker of Ozempic and Wegovy anti-obesity ...

Amy Schumer has been open about her use of GLP-1s to lose weight, but she likely didn't have a choice to fess up, as her ...

The Ozempic and Wegovy maker reports full-year sales of 309.1 billion Danish krone, beating analysts’ forecasts.

Meanwhile, Novo Nordisk said Tuesday that fourth-quarter sales of Wegovy rose 17% on year at constant exchange rates to 21.86 billion Danish kroner ($3.46 billion), while sales of Ozempic rose 1% to ...

The company said on Tuesday that sales could fall by as much as 13% this year, News.Az reports, citing Bloomberg. It cited pressure from lower ...

Before its mainstream surge in 2023, Ozempic was not a household name unless you had diabetes. But thanks to celebrity influence, it’s become the quick fix for those who want to lose excess pounds.

The Delhi High Court will review the EOW's report on a ₹157 crore counterfeit Ozempic scam involving Indian national Swapnadip Roy on February 6. | Latest News Delhi ...

Soon to implement a state-of-the-art lab, it's part of the college's new biotechnology lab. It’s meant to be an engineering hub set for possible future employees of pharmaceutical giant Eli ...

Novo Nordisk's stock plunged Tuesday after the maker of diabetes and weight-loss drugs Ozempic and Wegovy said it expects ...

Novo Nordisk beat analyst expectations for the fourth quarter, but the result was overshadowed by softened expectations for ...